• LAST PRICE
    6.4700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 6.4700
  • Day Range
    ---
  • 52 Week Range
    Low 6.2501
    High 6.5800
  • Volume
    ---
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSVA
Sinovac Biotech Ltd
639.9M
-1.8x
+15.89%
United StatesPIII
P3 Health Partners Inc
328.7M
-0.4x
---
United StatesNVAX
Novavax Inc
754.3M
-1.0x
---
United StatesPTCT
PTC Therapeutics Inc
2.4B
-3.8x
---
United StatesNOTV
Inotiv Inc
206.1M
-6.2x
---
United StatesALKS
Alkermes Plc
5.1B
10.0x
---
As of 2024-03-04

Company Information

Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Contact Information

Headquarters
No. 39 Shangdi Xi Road, Haidian DistrictBEIJING, BEJ, China 100085
Phone
108-289-0088
Fax
105-693-1800

Executives

Chairman of the Board, President, Chief Executive Officer, Secretary
WeiDong Yin
Chief Financial Officer, Vice President
Nan Wang
Chief Operating Officer, Vice President
Qiang Gao
Vice President - Quality and Production
Jing Li
Chief Business Officer, Investor Relations
Guang Yang

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$639.9M
Revenue (TTM)
$420.9M
Shares Outstanding
99.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-3.63
Book Value
$89.66
P/E Ratio
-1.8x
Price/Sales (TTM)
1.5
Price/Cash Flow (TTM)
---
Operating Margin
-358.88%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.